Denmark· DK-28104901111
Lymecyclin "Brown & Burk"
A lymecycline product containing lymecyclin, registered in Denmark by Brown & Burk IR Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Lymecycline is registered in 12 of 19 countries.
Countries holding a registration under ATC J01AA04 (lymecycline), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Lymecycline · ATC J01AA04
12 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of lymecycline costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lymecycline · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.52
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Lymecyclin
- Manufacturer
- Brown & Burk IR Limited
- Country
- Denmark (DK)
- ATC code
- J01AA04
- ATC class
- Lymecycline
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104901111
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
53 interactions on record for lymecycline.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lymecycline · interactions on record
53 records
53 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under J01AA04
Lymecycline, as other registers publish it.
- IrelandLycimor 300 mg Capsules, HardTeva B.V.
- DenmarkLymecyclin "Abacus Medicine"Abacus Medicine A/S
- DenmarkLymecyclin "Actavis"Actavis Group PTC ehf.
- DenmarkLymecyclin 2care42care4 ApS
- NorwayLymecyclin ActavisActavis Group PTC ehf
- DenmarkLymecyclin ActavisOrifarm A/S
- United KingdomLymecycline 408mg capsulesMedihealth (Northern) Ltd
- United KingdomLymecycline 408mg capsulesA A H Pharmaceuticals Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac63ac89-e704-4c27-b601-f8d867547732 GET /v1/drugs/ac63ac89-e704-4c27-b601-f8d867547732?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "kapsler, hårde",
"source": "dkma",
"strength": "300 mg",
"auth_role": "CMS",
"dk_drugid": "28104901111",
"substance": "Lymecyclin",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "41172"
}See everything about lymecycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.